Making sense of differences in pneumococcal serotype replacement-Reference-Cited by-同舟云学术

Making sense of differences in pneumococcal serotype replacement

Published:2019-06 Issue:6 Volume:19 Page:e213-e220
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Lewnard Joseph A,Hanage William P

Funder

National Institute for Allergy and Infectious Diseases, US National Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference69 articles.

1. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study;Ladhani;Lancet Infect Dis,2018

2. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP);Tomczyk;MMWR Morb Mortal Wkly Rep,2014

3. Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial;Goldblatt;Lancet Infect Dis,2018

4. When less is more: how many doses of PCV are enough?;O'Brien;Lancet Infect Dis,2018

5. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial;O'Brien;Lancet,2003

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health-economic burden attributable to novel serotypes in candidate 24- and 31-valent pneumococcal conjugate vaccines;Vaccine;2024-12

2. Nested inference of pairwise interactions from strain frequency data across settings and context-dependent mutual invasibilities;2024-09-10

3. Assessing the effect of social contact structure on the impact of pneumococcal conjugate vaccines;2024-08-20

4. Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges;Biologicals;2024-08

5. Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021;Frontiers in Public Health;2024-07-10